These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17332303)

  • 1. Mesothelin expression in human lung cancer.
    Ho M; Bera TK; Willingham MC; Onda M; Hassan R; FitzGerald D; Pastan I
    Clin Cancer Res; 2007 Mar; 13(5):1571-5. PubMed ID: 17332303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
    Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
    Li Q; Verschraegen CF; Mendoza J; Hassan R
    Anticancer Res; 2004; 24(3a):1327-35. PubMed ID: 15274292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.
    Steinbach D; Onda M; Voigt A; Dawczynski K; Wittig S; Hassan R; Gruhn B; Pastan I
    Eur J Haematol; 2007 Oct; 79(4):281-6. PubMed ID: 17803679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
    Plummer HK; Dhar MS; Cekanova M; Schuller HM
    BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.
    Hassan R; Laszik ZG; Lerner M; Raffeld M; Postier R; Brackett D
    Am J Clin Pathol; 2005 Dec; 124(6):838-45. PubMed ID: 16416732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts.
    Hassan R; Broaddus VC; Wilson S; Liewehr DJ; Zhang J
    Clin Cancer Res; 2007 Dec; 13(23):7166-71. PubMed ID: 18056197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
    Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
    Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
    Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
    Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.
    Onda M; Willingham M; Nagata S; Bera TK; Beers R; Ho M; Hassan R; Kreitman RJ; Pastan I
    Clin Cancer Res; 2005 Aug; 11(16):5840-6. PubMed ID: 16115924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesothelin as a potential therapeutic target in human cholangiocarcinoma.
    Yu L; Feng M; Kim H; Phung Y; Kleiner DE; Gores GJ; Qian M; Wang XW; Ho M
    J Cancer; 2010 Oct; 1():141-9. PubMed ID: 20922056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain.
    Johnson MD; Vito F; Xu H
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):250-3. PubMed ID: 20090516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.
    Illei PB; Alewine C; Zahurak M; Cowan ML; Montgomery E; Hassan R; Xiang L; Pastan I; Kelly RJ
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):246-52. PubMed ID: 26894650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway.
    Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF
    Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
    Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
    Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts.
    Hassan R; Williams-Gould J; Steinberg SM; Liewehr DJ; Yokokawa J; Tsang KY; Surawski RJ; Scott T; Camphausen K
    Clin Cancer Res; 2006 Aug; 12(16):4983-8. PubMed ID: 16914588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.
    Hassan R; Lerner MR; Benbrook D; Lightfoot SA; Brackett DJ; Wang QC; Pastan I
    Clin Cancer Res; 2002 Nov; 8(11):3520-6. PubMed ID: 12429643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.
    Zhang YF; Phung Y; Gao W; Kawa S; Hassan R; Pastan I; Ho M
    Sci Rep; 2015 May; 5():9928. PubMed ID: 25996440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.